TKI Plus Checkpoint Inhibitor Without Chemotherapy Shows Promise as Initial Option in Advanced NSCLC

Co-mutations in DNA Damage-Response Pathways May Predict Effectiveness of Checkpoint Inhibitors in NSCLC

Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors

The New WHO Classification of Lung Tumors

Lung Cancer Biomarker Testing Patterns Varied Widely in Japan

Envisioning A Tobacco-Free Generation

Controversy Regarding U.S. Marketing of New Heated Tobacco Product IQOS

Physician's Twitter Campaign Boosts UK Quit Smoking Efforts

Decade in Review: Changes in Smoking Behaviors Are Altering the Clinical Picture of Lung Cancer

Declaración de IASLC: dejar de fumar tras un diagnóstico de cáncer

Declaração da IASLC: cessação do tabagismo após o diagnóstico de câncer

IASLCからの宣言：癌診断後の禁煙